Aug 23, 2017

PaxVax’s Vaccine Platform & Other Research Build Momentum

PaxVax continues to evolve its approach for creating an HIV vaccine program, as the knowledge base and immune responses grow.

Jun 21, 2017

Nima Farzan Discusses Vaccine Development for Overlooked Infectious Diseases at BIO 2017

PaxVax seeks to develop vaccines for diseases that have been overlooked in markets that may not have as much commercial opportunity, but offer a great opportunity to make a social impact and a difference in people’s lives.

May 31, 2017

DoD Vaccine Research Saves Military, Civilian Lives

PaxVax works with the Walter Reed Army Institute of Research (WRAIR) to carry out the next human clinical trial for its chikungunya vaccine.

May 16, 2017

Lyon Leads Trial to Test Vaccine Aimed to Protect Military Troops

PaxVax is developing an important vaccine to fight adenovirus, a major cause of morbidity at military training centers, and Caroline Lyon, MD, MPH, is evaluating the safety and immunogenicity of the new vaccine.

Oct 31, 2016

We Need a Dose of Global Collaboration to Fight Zika

Progress is slow as industry players seek to develop a vaccine for Zika by working alone. PaxVax CEO, Nima Farzan, says global collaboration could help biotech and pharmaceutical companies combat outbreaks like Ebola and Zika before they become pandemics.

Jun 10, 2016

FDA Approves Cholera Vaccine for US Travelers

The FDA approves the PaxVax oral cholera vaccine for adults aged 18-64 who are traveling to countries affected by cholera.

May 17, 2016

Tackling Zika: Q&A With PaxVax CEO Nima Farzan

PaxVax CEO, Nima Farzan, says the company’s prior research and mission to address concerns of pandemic preparedness led to its decision to act quickly in developing a Zika candidate.

Mar 4, 2016

Vaccines 2016: Big Bets for Global Threats

PaxVax is among the array of companies working to develop a vaccine for Zika with hopes that it will help advance its social mission to positively impact the spread of infectious diseases in the developing world.

Feb 10, 2016

Zika Update: Vaccine Race Swells, PaxVax CEO on How to Stop ‘Chasing Epidemics’

Nima Farzan, PaxVax CEO, says the process for developing vaccines for neglected diseases could be more efficient if economic incentives were provided to biotech companies.

Feb 9, 2016

San Diego Company Testing Zika Vaccine

PaxVax launches efforts to develop a vaccine to protect people from being infected by the Zika virus.

Feb 7, 2016

Zika’s Threat Spurs Vaccine Research

PaxVax continues to advance its social mission by researching to develop a Zika vaccine before it spreads to unaffected areas and travelers become affected.

Dec 16, 2015

FDA Accepts PaxVax’s BLA for Cholera Vaccine, Grants it Priority Review

The FDA accepts and grants priority review of the Biologics License Application (BLA) for the PaxVax cholera vaccine.

1 of 3123